Hysteroscopic Surgery for Adenomyosis: When It May Help
Key Takeaways
Hysteroscopic surgery may help a small, carefully selected group of patients with adenomyosis, especially when the disease affects the uterine cavity or causes heavy bleeding that is visible from inside the uterus. It is not a universal treatment for adenomyosis, and fertility planning usually requires imaging, symptom review, and discussion of medical or other surgical options.
Key evidence: Systematic Review: Surgical Treatment of Adenomyosis ASRM: Fertility Evaluation of Infertile Women (2021)
Hysteroscopic Surgery for Adenomyosis
Adenomyosis occurs when endometrial-like tissue implants into the uterine muscle (myometrium) (Systematic Review on Adenomyosis Surgery).
While adenomyosis primarily affects the deep muscular wall, hysteroscopic surgery offers a targeted approach for selected cases where lesions distort or project directly into the uterine cavity.
For overall IVF planning, read adenomyosis and IVF.
What hysteroscopic cytoreductive surgery means
Hysteroscopic surgery is performed transcervically without abdominal incisions.
- Procedure: The surgeon accesses the uterine cavity using a narrow camera and specialized micro-instruments.
- Surgical goal: Resect, debulk, or coagulate cavity-facing adenomyotic tissue.
- Objective: Reduce heavy menstrual bleeding and restore normal endometrial cavity contours.
When it may be considered
Hysteroscopic cytoreduction is evaluated when:
- Submucosal lesions: Ultrasound or MRI identifies focal adenomyomas projecting into the cavity.
- Heavy menstrual bleeding: Menorrhagia is the primary symptom and conservative medical therapy fails.
- Implantation distortion: Cavity-distorting lesions interfere with embryo placement.
- Preservation goals: Patients seek a minimally invasive, uterine-sparing procedure.
Important limits
Hysteroscopy cannot treat deep myometrial disease. If adenomyosis is diffuse or located deep within the uterine wall, hysteroscopic treatment is insufficient.
Key clinical limitations:
- Incomplete treatment of deep myometrial disease.
- Risk of persistent dysmenorrhea or symptom recurrence.
- Limited evidence proving direct live-birth improvement compared to medical suppression.
High-resolution MRI or specialized transvaginal ultrasound is required prior to surgery to map lesion depth.
Fertility considerations
For infertile patients, surgical options must be weighed against non-surgical alternatives:
- Hormonal suppression: Pre-IVF GnRH agonist therapy to reduce inflammation.
- Frozen embryo transfer: Banking embryos prior to uterine preparation.
- Selective hysteroscopy: Reserved strictly for cavity-distorting lesions.
Risks and recovery
Potential risks include:
- Uterine perforation during tissue resection.
- Intrauterine adhesion formation (Asherman syndrome).
- Post-operative bleeding or pelvic infection.
- Incomplete symptom relief requiring secondary therapy.
Recovery is rapid, but ongoing clinical follow-up is necessary to monitor cavity healing and symptom response.
Related Reading
- Hysteroscopy in Female Infertility: When It Helps and When It Is Not Routine
- Adenomyosis and IVF: When It Matters and How Treatment Is Tailored
- Fibroids and IVF: When Fibroids Matter and When They Do Not
FAQ
Is hysteroscopic surgery a standard treatment for adenomyosis?
No. It is a selective option, mainly when adenomyotic tissue affects the uterine cavity or bleeding symptoms point to a cavity-facing component.
Can hysteroscopy remove all adenomyosis?
Usually not. Most adenomyosis extends into the uterine muscle, and hysteroscopy can only reach disease that is visible or accessible from inside the cavity.
Does hysteroscopic treatment improve fertility in every patient?
No. It may help selected patients, but fertility benefit depends on where the disease is, how extensive it is, and what other reproductive factors are present.
Hysteroscopic cytoreductive surgery is not a standard answer for all adenomyosis. It may help selected patients with cavity-facing disease or bleeding-dominant symptoms, but many patients need a broader fertility and symptom strategy based on imaging, reproductive goals, and the extent of myometrial involvement.
Sources
- ASRM: Fertility Evaluation of Infertile Women (2021)
- Adenomyosis and Infertility: A Literature Review
- Adenomyosis and Infertility: Review of Medical and Surgical Approaches
- The Outcome of Fertility-Sparing and Nonfertility-Sparing Surgery for the Treatment of Adenomyosis: A Systematic Review and Meta-analysis
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.